Patent · US Expired

Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity

US6191102A · kind A · utility

270Cited by

0References

20Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Richard D. DiMarchi · Carmel, US
Suad Efendic · Lidingö, SE

Key dates

Filing date	Oct 30, 1997
Grant date	Feb 20, 2001
Priority date	—
Expiry date	Oct 30, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.